References
- Ammassari, A., Trotta, M. P., Murri, R., Castelli, F., Narciso, P., Noto, P., et al. (2002). Correlates and predictors of compliance to highly active antiretroviral therapy: Overview of published literature. J. Acquir. Immune Defic. Syndr., 31, 123-127.
- Anonymous (1994). Development of the WHOQOL: Rational and current status. Int. J. Mental Health, 23 (3), 24-56.
- Ansell, J., Hirsh, J., Hylek, E., Jacobson, A., Crowther, M., Palareti, G. (2008). Pharmacology and management of the vitamin K antagonists: American college of chest physicians evidence-based clinical practice guidelines. Chest, 133, 160-198.
- Bushnell, C. D., Olson, D. M., Zhao, X., Pan, W., Zimmer, L. O., Goldstein, L. B., Alberts, M. J., Fagan, S. C., Fonarow, G. C., Johnston, S. C., Kidwell, C., LaBresh, K. A., Ovbiagele, B., Schwamm, L., Peterson, E. D. (2011). Secondary preventive medication persistence and compliance 1 year after stroke. Neurology, 77 (12), 1182-1190.
- Chen, S. Y., Wu, N., Gulseth, M., LaMori, J., Bookhart, B. K., Boulanger, L., et al. (2013). One-year compliance to warfarin treatment for venous thromboembolism in high-risk patients and its association with long-term risk of recurrent events. J. Manag. Care Pharm., 19 (4), 291-301.
- Deitelzweig, S. B, Lin, J., Kreilick, C., Hussein, M., Battleman, D. (2010). Warfarin therapy in patients with venous thromboembolism: Patterns of use and predictors of clinical outcomes. Adv. Ther., 27 (9), 623-633.
- DeWilde, S., Carey, I. M., Emmas, C., Richards, N., Cook, D. G. (2006). Trends in the prevalence of diagnosed atrial fibrillation, its treatment with anticoagulation and predictors of such treatment in UK primary care. Heart, 92 (8), 1064-1070.
- DiMatteo, M. R., Giordani, P. J., Lepper, H. S., Croghan, T. W. (2002). Patient compliance and medical treatment outcomes: A meta-analysis. Med. Care, 40 (9), 794-811.
- Fang, M. C., Go, A. S., Chang, Y., Borowsky, L. H., Pomernacki, N. K., Udaltsova, N., Singer, D. E. (2010). Warfarin discontinuation after starting warfarin for atrial fibrillation. Circ. Cardiovasc. Qual. Outcomes, 3 (6), 624-631.
- Ganz, D. A., Glynn, R. J., Mogun, H., Knight, E. L., Bohn, R. L., Avorn, J. (2000). Compliance to guidelines for oral anticoagulation after venous thrombosis and pulmonary embolism. J. Gen. Intern. Med., 15 (11), 776-781.
- Haynes, R. B., McDonald, H. P., Garg, A. X. (2002). Helping patients follow prescribed treatment. J. Amer. Med. Assoc., 288 (22), 2880-2883.
- Hylek, E. M., Singer, D. E. (1994). Risk factors for intracranial hemorrhage in outpatients taking warfarin. Ann. Intern. Med., 120 (11), 897-902.
- Hylek, E. M., Skates, S. J., Sheehan, M. A., Singer, D. E. (1996). An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation. New Engl. J. Med., 335 (8), 540-546.
- Jackevicius, C. A., Mamdani, M., Tu, J. V. (2002). Compliance with statin therapy in elderly patients with and without acute coronary syndromes. J. Amer. Med. Assoc., 288 (4), 462-467.
- Johnston, J. A., Cluxton, R. J. Jr, Heaton, P. C., Guo, J. J., Moomaw, C. J., Eckman, M. H. (2003). Predictors of warfarin use among Ohio medic aid patients with new-onset nonvalvular atrial fibrillation. Arch. Intern. Med., 163 (14), 1705-1710.
- Kimmel, S. E., Chen, Z., Price, M., Parker, C. S., Metlay, J. P., Christie, J. D., Brensinger, C. M., Newcomb, C. W., Samaha, F. F., Gross, R. (2007). The influence of patient compliance on anticoagulation control with warfarin: Results from the international normalized ratio compliance and genetics (IN-RANGE) study. Arch, Intern. Med., 167 (3), 229-235.
- Lacro, J. P., Dunn, L. B., Dolder, C. R., Leckband, S. G., Jeste, D. V. (2002). Prevalence of and risk factors for medication noncompliance in patients with schizophrenia: A comprehensive review of recent literature. J. Clin. Psychiatry, 63 (10), 892-909.
- Misdrahi, D., Llorca, P. M., Lancon, C., Bayle, F. J. (2002). Compliance in schizophrenia: Predictive factors, therapeutical considerations and research implications. Encephale, 28, 266-272.
- Okuno, J., Yanagi, H., Tomura, S. (2001). Is cognitive impairment a risk factor for poor compliance among Japanese elderly in the community? Eur. J. Clin. Pharmacol., 57 (8), 589-594.
- Osterberg, L., Blaschke, T. (2005). Compliance to medication. New Engl. J. Med., 353 (5), 487-497.
- Samsa, G., Matchar, D. B., Dolor, R. J., Wiklund, I., Hedner, E., Wygant, G., Hauch, O., Marple, C. B., Edwards, R. (2004). A new instrument for mea- suring anticoagulation-related quality of life: Development and preliminary validation. Health and Quality of Life Outcomes, 2, 22.
- Sewitch, M. J., Abrahamowicz, M., Barkun, A., Bitton, A., Wild, G. E., Cohen, A., Dobkin, P. L. (2003). Patient noncompliance to medication in inflammatory bowel disease. Amer. J. Gastroenterol., 98 (7), 1535-1544.
- Stilley, C. S., Sereika, S., Muldoon, M. F., Ryan, C. M., Dunbar-Jacob, J. (2004). Psychological and cognitive function: Predictors of compliance with cholesterol lowering treatment. Ann. Behav. Med., 27 (2), 117-124.
- Urquhart, J. (2002). The odds of the three nons when an aptly prescribed medicine isn’t working: Non-compliance, non-absorption, non-response. Brit. J. Clin. Pharmacol., 54 (2), 212-220.
- Van Servellen, G., Chang, B., Garcia, L., Lombardi, E. (2002). Individual and system level factors associated with treatment noncompliance in human immunodeficiency virus-infected men and women. AIDS Patient Care, 16 (6), 269-281.
- Van Walraven, C., Jennings, A., Oake, N., Fergusson, D., Forster, A. J. (2006). Effect of study setting on anticoagulation control: A systematic review and metaregression. Chest, 129 (5), 1155-1166.